- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: lenalidomide (Revlimid)
Total 1146 results
-
CelgeneCompletedLeukemia Lymphocytic Chronic B-CellUnited States, Austria
-
National Heart, Lung, and Blood Institute (NHLBI)Celgene CorporationCompletedBone Marrow Diseases | Chronic Myelomonocytic Leukemia | Neutropenia | Acute Myeloid Leukemia (AML) | Myeldysplastic Syndrome (MDS)United States
-
National Cancer Institute (NCI)Millennium Pharmaceuticals, Inc.Withdrawn
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedEverolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin LymphomaRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
CelgeneCompletedDiffuse Large B-cell LymphomaUnited States, Australia, Italy, Spain, France, Austria, Sweden, Czechia, United Kingdom
-
CelgeneCompleted
-
CelgeneCompletedMultiple MyelomaCanada, Denmark, Australia, Belgium, France, Germany, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom, Czechia, Greece
-
CelgeneCompleted
-
CelgeneICON Clinical ResearchCompletedMelanoma | Neoplasm MetastasisAustralia, United Kingdom, Ukraine, Germany, Estonia, Latvia, Lithuania, Netherlands, South Africa
-
CelgeneCompletedMyelodysplastic SyndromeUnited States
-
CelgeneCompletedPeripheral T-cell Lymphoma | Adult T-cell Leukemia-LymphomaJapan
-
Shandong Provincial HospitalUnknown
-
Attaya SuvannasankhaCelgeneCompletedLenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple MyelomaMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Celgene CorporationCompletedRefractory/Relapsed Indolent Non-Hodgkin LymphomaUnited States
-
CelgeneActive, not recruiting
-
Royal Marsden NHS Foundation TrustCelgene CorporationActive, not recruitingDiffuse Large B-Cell LymphomaUnited Kingdom
-
The First Hospital of Jilin UniversityUnknownMultiple Myeloma in RelapseChina
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Mingzhi ZhangUnknownNK/T Cell LymphomaChina
-
Biotest Pharmaceuticals CorporationBiotestCompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
Ruijin HospitalUnknown
-
University Hospital, LimogesMinistry of Health, France; Celgene CorporationCompleted
-
Novartis PharmaceuticalsCompletedPrevention of Acute Rejection in Paediatric Recipients of a Renal TransplantGermany, United Kingdom, France, Italy, United States, Hungary, Norway, Spain, Argentina, Brazil, Poland, Sweden, Turkey
-
JW PharmaceuticalCompletedMultiple MyelomaKorea, Republic of, United States
-
Vanderbilt-Ingram Cancer CenterBristol-Myers Squibb; National Cancer Institute (NCI)TerminatedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Central Nervous System Lymphoma | Recurrent Central Nervous System LymphomaUnited States
-
Multinational Center for Quality of Life Research...Unknown
-
Millennium Pharmaceuticals, Inc.Completed
-
Incyte CorporationNovartis PharmaceuticalsCompletedPolycythemia VeraUnited States, Canada, France, Italy, United Kingdom, China, Belgium, Germany, Spain, Turkey, Japan, Australia, Korea, Republic of, Netherlands, Russian Federation, Argentina, Thailand, Hungary
-
Vejle HospitalThe University of Hong KongCompleted
-
Assistance Publique - Hôpitaux de ParisUnknown
-
The First Affiliated Hospital with Nanjing Medical...UnknownDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma RefractoryChina
-
Gruppo Italiano Malattie EMatologiche dell'AdultoTerminatedChronic Lymphocytic LeukemiaItaly
-
Pharmacyclics LLC.Celgene CorporationCompletedDiffuse Large B Cell Lymphoma Refractory | Diffuse Large B Cell Lymphoma RelapsedUnited States
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerUnited States, Germany, Belgium, Canada, France, Italy, Spain, United Kingdom, Austria, Argentina, Sweden, Hungary, Korea, Republic of, Lebanon, Bulgaria, Greece, Thailand, Netherlands, Colombia, Norway, Finland, Poland
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedChronic Lymphocytic LeukemiaItaly
-
Sherif S. FaragCelgene CorporationTerminatedMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaHong Kong, Korea, Republic of, Singapore
-
Fondazione EMN Italy OnlusCompleted
-
CelgeneCompletedRelapsed or Refractory Chronic Lymphocytic LeukemiaUnited States, Canada, United Kingdom, France, Germany, Spain, Italy, Sweden
-
CelgeneCompletedMultiple MyelomaUnited States, Netherlands, Canada, Belgium, United Kingdom, Australia, Denmark, Germany, Spain, Switzerland, France, Italy, Greece, Russian Federation, Sweden, Czechia
-
Associazione Qol-oneTerminatedMyelodysplastic SyndromesFrance, Italy, Greece
-
Singapore General HospitalNational University Hospital, Singapore; National Cancer Center Singapore,... and other collaboratorsWithdrawnEBV Related Non-Hodgkin's Lymphoma | Primary CNS Lymphoma | Primary Testicular LymphomaSingapore
-
Dartmouth-Hitchcock Medical CenterCelgene CorporationTerminatedNeuropathy | Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)United States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...MedImmune LLCCompleted
-
Fondazione EMN Italy OnlusCompleted
-
Peng LiuChipscreen Biosciences, Ltd.Unknown